A Phase Ib Study Of The Safety And Pharmacology Of Atezolizumab (Anti−PD-L1 Antibody) Administered With Erlotinib Or Alectinib In Patients With Advanced Non−Small Cell Lung Cancer

UCI-15-46
NCT02013219
Cancer - Lung
Sai-Hong Ignatius Ou
Open
Treatment
Alectinib, Atezolizumab, Erlotinib, MPDL3280A, OSI-774, Tarceva
Ib/II
Adult
Local

For information about cancer clinical trials at the UC Irvine Health Chao Family Comprehensive Cancer Center, call toll-free 877-UC-STUDY (877-827-8839) or email ucstudy@uci.edu.